【摘要】：正為保護(hù)人的生命和健康,維護(hù)人的尊嚴(yán),尊重和保護(hù)受試者的合法權(quán)益,規(guī)范涉及人的生物醫(yī)學(xué)研究倫理審查工作,國(guó)家衛(wèi)生和計(jì)劃生育委員會(huì)于2016年10月12日發(fā)布了《涉及人的生物醫(yī)學(xué)研究倫理審查辦法》(以下簡(jiǎn)稱《辦法》),自2016年12月1日起施行。該《辦法》適用于各級(jí)各類醫(yī)療衛(wèi)生機(jī)構(gòu)開展涉及人的生物醫(yī)學(xué)研究倫理審查工作。文件中所稱涉及人的生物醫(yī)學(xué)研究包括以下活動(dòng):(1)采用現(xiàn)代物理學(xué)、化學(xué)、生物學(xué)、中醫(yī)藥學(xué)和心理學(xué)等方法對(duì)人的生理、心
[Abstract]:It is protecting the human life and health, protecting human dignity, respecting and protecting the legitimate rights and interests of the subject, and regulating the ethical review of the human biomedical research. The National Health and Family Planning Commission, on 12 October 2016, issued a "Ethical Review of Biomedical Research Involving Human" (hereinafter referred to as the ), which is effective as of December 1,2016. The is applicable to various medical and health institutions at all levels to conduct ethical review of biomedical research involving human beings. The biomedical research of the person referred to in the document includes the following activities: (1) the use of modern physics, chemistry, biology, traditional Chinese medicine and psychology, and other methods to the physiology and heart of human beings
【分類號(hào)】：+
，

本文編號(hào)：2515447

qikan